Parkinson’s disease causality and heterogeneity: a proteogenomic view
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge Del-Aguila, Jacob Marcus, Neha Raghavan, David Stone, Olumide Fagboyegun, Douglas Galasko, Mohammed Dakna, Bilada Bilican, Mary Dovlatyan, Anna Kostikova, Jingyao Li, Brant Peterson, Michael Rotte, Vinicius Sanz, Tatiana Foroud, Samantha J. Hutten, Mark Frasier, Hirotaka Iwaki, Andrew Singleton, Ken Marek, Karen Crawford, Fiona Elwood, Mirko Messa, View ORCID ProfilePablo Serrano-Fernandez
doi: https://doi.org/10.1101/2022.03.09.22272131
Sergio Kaiser
1Translational Medicine Department. Novartis Institutes for Biomedical Research. Basel, Switzerland
Luqing Zhang
2Cardiovascular and Metabolism Department. Novartis Institutes for Biomedical Research. Cambridge, USA
Brit Mollenhauer
3Department of Neurology, University Medical Center Göttingen. Göttingen, Germany
Jaison Jacob
2Cardiovascular and Metabolism Department. Novartis Institutes for Biomedical Research. Cambridge, USA
Simonne Longerich
5Genome and Biomarker Sciences. Merck Exploratory Science Center. Cambridge, USA
Jorge Del-Aguila
5Genome and Biomarker Sciences. Merck Exploratory Science Center. Cambridge, USA
Jacob Marcus
5Genome and Biomarker Sciences. Merck Exploratory Science Center. Cambridge, USA
Neha Raghavan
5Genome and Biomarker Sciences. Merck Exploratory Science Center. Cambridge, USA
David Stone
6Department of Genetics, Cerevel Therapeutics. Cambridge, USA
Olumide Fagboyegun
6Department of Genetics, Cerevel Therapeutics. Cambridge, USA
Douglas Galasko
7Department of Neurosciences, University of Southern California, San Diego. La Jolla, USA
Mohammed Dakna
3Department of Neurology, University Medical Center Göttingen. Göttingen, Germany
Bilada Bilican
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Mary Dovlatyan
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Anna Kostikova
1Translational Medicine Department. Novartis Institutes for Biomedical Research. Basel, Switzerland
Jingyao Li
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Brant Peterson
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Michael Rotte
1Translational Medicine Department. Novartis Institutes for Biomedical Research. Basel, Switzerland
Vinicius Sanz
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Tatiana Foroud
8Department of Medical and Molecular Genetics, Indiana University School of Medicine. Indianapolis, USA
Samantha J. Hutten
9Michael J. Fox Foundation for Parkinson’s Research. New York, USA
Mark Frasier
9Michael J. Fox Foundation for Parkinson’s Research. New York, USA
Hirotaka Iwaki
10Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health. Bethesda, USA
Andrew Singleton
10Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health. Bethesda, USA
Ken Marek
11Institute for Neurodegenerative Disorders. New Haven, USA
Karen Crawford
12Laboratory of Neuroimaging, University of Southern California. Los Angeles, USA
Fiona Elwood
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Mirko Messa
4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
Pablo Serrano-Fernandez
1Translational Medicine Department. Novartis Institutes for Biomedical Research. Basel, Switzerland
Data Availability
The results of the current study are publicly available on the LONI database and all data produced in the present work are contained in the manuscript
Posted June 14, 2022.
Parkinson’s disease causality and heterogeneity: a proteogenomic view
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge Del-Aguila, Jacob Marcus, Neha Raghavan, David Stone, Olumide Fagboyegun, Douglas Galasko, Mohammed Dakna, Bilada Bilican, Mary Dovlatyan, Anna Kostikova, Jingyao Li, Brant Peterson, Michael Rotte, Vinicius Sanz, Tatiana Foroud, Samantha J. Hutten, Mark Frasier, Hirotaka Iwaki, Andrew Singleton, Ken Marek, Karen Crawford, Fiona Elwood, Mirko Messa, Pablo Serrano-Fernandez
medRxiv 2022.03.09.22272131; doi: https://doi.org/10.1101/2022.03.09.22272131
Parkinson’s disease causality and heterogeneity: a proteogenomic view
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge Del-Aguila, Jacob Marcus, Neha Raghavan, David Stone, Olumide Fagboyegun, Douglas Galasko, Mohammed Dakna, Bilada Bilican, Mary Dovlatyan, Anna Kostikova, Jingyao Li, Brant Peterson, Michael Rotte, Vinicius Sanz, Tatiana Foroud, Samantha J. Hutten, Mark Frasier, Hirotaka Iwaki, Andrew Singleton, Ken Marek, Karen Crawford, Fiona Elwood, Mirko Messa, Pablo Serrano-Fernandez
medRxiv 2022.03.09.22272131; doi: https://doi.org/10.1101/2022.03.09.22272131
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12806)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1200)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)